As of June 2023 Hikma Pharmaceuticals has a market cap of $5.03 Billion. This makes Hikma Pharmaceuticals the world's 2447th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $5.03 B | 23.06% |
2022 | $4.08 B | -50.53% |
2021 | $8.26 B | -5.71% |
2020 | $8.76 B | 18.37% |
2019 | $7.40 B | 26.93% |
2018 | $5.83 B | 41.28% |
2017 | $4.12 B | -36.34% |
2016 | $6.48 B | -29.81% |
2015 | $9.24 B | 17.75% |
2014 | $7.84 B | 67.51% |
2013 | $4.68 B | 58.21% |
2012 | $2.96 B | 33.03% |
2011 | $2.22 B | -19.09% |
2010 | $2.75 B | 51.46% |
2009 | $1.81 B | 89.85% |
2008 | $0.95 B | -54.68% |
2007 | $2.11 B | 21.83% |
2006 | $1.73 B |
On Jun 8th, 2023 the market cap of Hikma Pharmaceuticals was reported to be: